Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Adam Goulburn


Dr. Adam Goulburn serves as Partner at Lux Capital. He is based in the firm's New York headquarters and focuses on broad investment opportunities in healthcare IT, services, mobile health and therapeutics. He was a Board Member of Authorea. He has worked extensively with a number of Lux portfolio companies including Kala Pharmaceuticals and Genocea Biosciences. He is also a mentor for healthcare IT incubators Blueprint Health and Healthbox. Before joining Lux, he was a Postdoctoral Fellow of Neuroscience at Weill Cornell Medical College, researching regenerative medicine in association with brain disorders including schizophrenia and Alzheimer's disease. Originally from Australia, he has dual undergraduate degrees in Commerce and Science and subsequently completed his Ph.D. at the Australian Stem Cell Centre, having been chosen as a highly selective Premier Scholar. He has published in numerous peer-reviewed scientific journals. Prior to joining Lux in 2011, he received his Ph.D. in neuroscience from Weill Cornell Medical College. He also serves as a Board Member at He previously served as a Board Member at 3Scan.

Primary Investor Type
Angel (individual)
Primary Office
  • 920 Broadway
  • 11th Floor
  • New York, NY 10010
  • United States

+1 (646) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adam Goulburn’s full profile, request a free trial.

Adam Goulburn Team (1)

Name Title Deals Funds Boards Office Contact
Adam Goulburn Ph.D Angel Investor 00 0 0 New York, NY